RFG Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $227K | Sell |
1,407
-554
| -28% | -$89.4K | 0.01% | 867 |
|
2025
Q1 | $334K | Buy |
1,961
+51
| +3% | +$8.68K | 0.01% | 688 |
|
2024
Q4 | $317K | Buy |
+1,910
| New | +$317K | 0.01% | 633 |
|
2023
Q1 | – | Sell |
-1,659
| Closed | -$272K | – | 642 |
|
2022
Q4 | $272K | Sell |
1,659
-68
| -4% | -$11.1K | 0.01% | 531 |
|
2022
Q3 | $254K | Sell |
1,727
-140
| -7% | -$20.6K | 0.01% | 527 |
|
2022
Q2 | $279K | Buy |
+1,867
| New | +$279K | 0.02% | 476 |
|
2021
Q4 | – | Sell |
-3,033
| Closed | -$504K | – | 482 |
|
2021
Q3 | $504K | Buy |
3,033
+542
| +22% | +$90.1K | 0.04% | 272 |
|
2021
Q2 | $430K | Sell |
2,491
-248
| -9% | -$42.8K | 0.04% | 293 |
|
2021
Q1 | $440K | Sell |
2,739
-595
| -18% | -$95.6K | 0.05% | 275 |
|
2020
Q4 | $582K | Sell |
3,334
-378
| -10% | -$66K | 0.08% | 218 |
|
2020
Q3 | $584K | Buy |
3,712
+327
| +10% | +$51.4K | 0.08% | 209 |
|
2020
Q2 | $568K | Sell |
3,385
-91
| -3% | -$15.3K | 0.09% | 190 |
|
2020
Q1 | $456K | Buy |
3,476
+128
| +4% | +$16.8K | 0.09% | 193 |
|
2019
Q4 | $498K | Buy |
3,348
+193
| +6% | +$28.7K | 0.08% | 199 |
|
2019
Q3 | $390K | Buy |
3,155
+545
| +21% | +$67.4K | 0.08% | 199 |
|
2019
Q2 | $367K | Sell |
2,610
-13
| -0.5% | -$1.83K | 0.08% | 197 |
|
2019
Q1 | $397K | Sell |
2,623
-526
| -17% | -$79.6K | 0.1% | 166 |
|
2018
Q4 | $391K | Sell |
3,149
-263
| -8% | -$32.7K | 0.1% | 165 |
|
2018
Q3 | $541K | Buy |
3,412
+1,163
| +52% | +$184K | 0.14% | 147 |
|
2018
Q2 | $315K | Buy |
2,249
+312
| +16% | +$43.7K | 0.09% | 161 |
|
2018
Q1 | $257K | Sell |
1,937
-12
| -0.6% | -$1.59K | 0.1% | 162 |
|
2017
Q4 | $246K | Hold |
1,949
| – | – | 0.11% | 162 |
|
2017
Q3 | $245K | Buy |
+1,949
| New | +$245K | 0.15% | 134 |
|